Elizabeth A. Johnson

5.1k total citations · 1 hit paper
130 papers, 3.7k citations indexed

About

Elizabeth A. Johnson is a scholar working on Oncology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Elizabeth A. Johnson has authored 130 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 20 papers in Public Health, Environmental and Occupational Health and 19 papers in General Health Professions. Recurrent topics in Elizabeth A. Johnson's work include Ethics in Clinical Research (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (8 papers). Elizabeth A. Johnson is often cited by papers focused on Ethics in Clinical Research (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (8 papers). Elizabeth A. Johnson collaborates with scholars based in United States, Canada and Australia. Elizabeth A. Johnson's co-authors include James E. Herndon, Dorothy Watson, David W. Johnstone, David J. Sugarbaker, Michael A. Maddaus, Gary M. Strauss, Richard L. Schilsky, Everett E. Vokes, Mark R. Green and Heidi H. Gillenwater and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth A. Johnson

122 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

2008 690 citations Gary M. Strauss, James E. Herndon et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Elizabeth A. Johnson

Since Specialization

Citations

This map shows the geographic impact of Elizabeth A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Johnson more than expected).

Fields of papers citing papers by Elizabeth A. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Johnson. The network helps show where Elizabeth A. Johnson may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Johnson. A scholar is included among the top collaborators of Elizabeth A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Johnson. Elizabeth A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Linguistic dissection of nursing handoffs: Implications for patient safety in varied‐acuity hospital settings 2024 ·Journal of Clinical Nursing ·(unknown), Elizabeth A. Johnson, (unknown), (unknown)	3
2	Understanding Learning Engagement with User-Centered Human-Computer Interaction in a Multimodal Online Learning Environment 2023 ·Proceedings of the Human Factors and Ergonomics Society Annual Meeting ·Jiahui Ma, Elizabeth A. Johnson, (unknown)	1
3	Serving on the Front Lines of Higher Education: Exploring Advisors' Coping During COVID-19 2023 ·NACADA Journal ·(unknown), Elizabeth A. Johnson	2
4	When to err is inhuman: An examination of the influence of artificial intelligence‐driven nursing care on patient safety 2023 ·Nursing Inquiry ·Elizabeth A. Johnson, (unknown), Jane M. Carrington	13
5	Reimagining the joint task force core competency framework for rural and frontier clinical research professionals conducting hybrid and decentralized trials 2023 ·Frontiers in Pharmacology ·(unknown), Elizabeth A. Johnson, Jiahui Ma, (unknown)	2
6	Exploration of Lived Experiences and Measurement of Burnout Among US Clinical Research Nurses 2023 ·JONA The Journal of Nursing Administration ·Elizabeth A. Johnson, Jessica G. Rainbow	2
7	Trouble for trials - The worrying state of the research nurse workforce 2022 ·Contemporary Clinical Trials ·Elizabeth A. Johnson	6
8	Validation of a Dietary Screening Tool in a Middle-Aged Appalachian Population 2018 ·Nutrients ·Melissa Ventura Marra, Sowmyanarayanan Thuppal, Elizabeth A. Johnson, Regan L Bailey	17
9	Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution 2016 ·Surgical Endoscopy ·John Stauffer, Alessandro Coppola, (unknown), Kabir Mody, Elizabeth A. Johnson, Zhuo Li, Horacio J. Asbun	115
10	Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups breakdown → 2008 ·Journal of Clinical Oncology ·Gary M. Strauss, James E. Herndon, Michael A. Maddaus, David W. Johnstone, Elizabeth A. Johnson, David H. Harpole, Heidi H. Gillenwater, Dorothy Watson, David J. Sugarbaker, Richard L. Schilsky, Everett E. Vokes, Mark R. Green	690
11	Effects of Varying Post-Warm-Up Recovery Time on 200-m Time-Trial Swim Performance 2007 ·International Journal of Sports Physiology and Performance ·(unknown), Elizabeth A. Johnson, Gordon G. Sleivert	42
12	Nature in Fragments 2005 ·Columbia University Press eBooks ·Elizabeth A. Johnson, Michael W. Klemens	36
13	Phase II Trial of Vinorelbine Plus Doxorubicin in Relapsed Small-Cell Lung Cancer 2004 ·American Journal of Clinical Oncology ·Elizabeth A. Johnson, Diana Lake, James E. Herndon, (unknown), Thomas J. Lynch, Mark R. Green	6
14	Brain concentrations of d-MDMA are increased after stress 2004 ·Psychopharmacology ·Elizabeth A. Johnson, James P. O’Callaghan, Diane B. Miller	45
15	Colinearity of Reverse Transcriptase Inhibitor Resistance Mutations Detected by Population-Based Sequencing 2003 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Matthew J. Gonzales, Elizabeth A. Johnson, Kathryn Dupnik, Tomozumi Imamichi, Robert W. Shafer	13
16	Aberrant p53 Staining Does Not Predict Cisplatin Resistance in Locally Advanced Non-Small Cell Lung Cancer 2002 ·Cancer Investigation ·Elizabeth A. Johnson, David S. Klimstra, James E. Herndon, Edison Catalano, George P. Canellos, Stephen L. Graziano, Jeffrey A. Kern, Mark R. Green	7
17	Naming God She: The Theological Implications 2000 ·ScholarlyCommons (University of Pennsylvania) ·Elizabeth A. Johnson	0
18	Abnormal fatty acid composition in sarcolemma and sarcoplasmic reticulum from myotonic ADR mouse muscle 1993 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Dale L. Birkle, (unknown), (unknown), Elizabeth A. Johnson, Jack E. Riggs, Albert J. Azzaro	4
19	Continuous Infusion 5-Fluorouracil with Bolus Adriamycin and Mitomycin and Low-Dose Cisplatin (FAMP) in the Treatment of Metastatic Gastric Carcinoma: An Evaluation of Efficacy and Toxicity 1991 ·Cancer Investigation ·James Raschko, Elizabeth A. Johnson, Winston Ueno, Paul V. Woolley, Joseph Treat	4
20	Anomalous sound propagation and mode degeneracy in noble gas mixtures 1986 ·Proceedings of the Royal Society of London A Mathematical and Physical Sciences ·John R. Bowler, Elizabeth A. Johnson	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact